Virtual Library

Start Your Search

  • WCLC 2017

    18th World Conference on Lung Cancer

    Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan

    Presentation Date(s):  
    • Oct 15 - 18, 2017
    • Total Presentations: 2295

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Download PDF of the Conference Program: Click Here.
    Onsite Conference Program Addendum (17/10/2017): Click Here.
    Download PDF of the Abstract Book: Click Here.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    P1.01 - Advanced NSCLC

    • Type: Poster Session with Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 80
    • Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P1.01-001 - Depth of Target Lesion Response to Brigatinib and Its Association With Outcomes in Patients With ALK+ NSCLC in the ALTA Trial

      09:30 - 09:30  |  Presenter: D. Ross Camidge

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.01-070 - BIW-8962, an Anti-GM2 Ganglioside Monoclonal Antibody, in Advanced/Recurrent Lung Cancer: A Phase I/II Study

      09:30 - 09:30  |  Author(s): J. Lee

      • Abstract

      Loading...

  • +

    P1.15 - SCLC/Neuroendocrine Tumors

    • Type: Poster Session with Presenters Present
    • Track: SCLC/Neuroendocrine Tumors
    • Presentations: 17
    • Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P1.15-004 - An Open-Label, Multitumor Phase II Basket Study of Olaparib and Durvalumab (MEDIOLA): Results in Patients with Relapsed SCLC

      09:30 - 09:30  |  Presenter: Matthew G Krebs

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MS 07 - Neuroendocrine Tumors other than SCLC: Pathology to Patient Management

    • Type: Mini Symposium
    • Track: SCLC/Neuroendocrine Tumors
    • Presentations: 7
    • Moderators:C. Barrios
    • Coordinates: 10/16/2017, 15:45 - 17:30, F203 + F204 (Annex Hall)
  • +

    OA 05 - Next Generation TKI

    • Type: Oral
    • Track: Advanced NSCLC
    • Presentations: 9
    • +

      OA 05.03 - Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients with EGFR Activating and T790M Mutations

      16:05 - 16:15  |  Presenter: Keunchil Park

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA 05.05 - Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Updated Efficacy and Safety Results From ALTA, a Randomized Phase 2 Trial

      16:30 - 16:40  |  Presenter: Myung-Ju Ahn

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA 05.07 - Efficacy and Updated Safety of Ceritinib (450 Mg or 600 Mg) with Low-Fat Meal vs 750 Mg Fasted in ALK+ Metastatic NSCLC

      16:50 - 17:00  |  Presenter: Byoung Chul Cho

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA 09 - EGFR TKI Resistance

    • Type: Oral
    • Track: Advanced NSCLC
    • Presentations: 8
    • +

      OA 09.03 - TATTON Ph Ib Expansion Cohort: Osimertinib plus Savolitinib for Pts with EGFR-Mutant MET-Amplified NSCLC after Progression on Prior EGFR-TKI

      11:20 - 11:30  |  Presenter: Myung-Ju Ahn

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.01 - Advanced NSCLC

    • Type: Poster Session with Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 97
    • Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P3.01-005 - ASTRIS: A Real World Study of Osimertinib Treatment in Patients with EGFR T790M Positive Advanced NSCLC; Interim Analysis

      09:30 - 09:30  |  Presenter: Sang-We Kim

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P3.01-050 - A Real World Treatment Study of Osimertinib: ASTRIS Study Korean Subgroup Analysis

      09:30 - 09:30  |  Presenter: Byoung Chul Cho

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.